JACOB BEANE: Open Payments
NPI 1063100873 · CRANSTON, RI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,231 in 63 payments from 16 companies in 2025. Trend: 2023 $83 · 2024 $910 · 2025 $1,231
Food & beverage: $1,231
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $314 |
| ABBVIE INC. | 14 | $191 |
| Lilly USA, LLC | 9 | $189 |
| Kowa Pharmaceuticals America, Inc. | 6 | $104 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $89 |
| Novartis Pharmaceuticals Corporation | 4 | $73 |
| PFIZER INC. | 3 | $50 |
| Exact Sciences Corporation | 2 | $44 |
| Merck Sharp & Dohme LLC | 2 | $33 |
| Seqirus USA Inc | 1 | $27 |
Products named: AIRSUPRA, MOUNJARO, QULIPTA, JARDIANCE, ZORYVE, BREZTRI, FARXIGA, UBRELVY.
Industry payments across RI — which companies pay providers there.
